AKT1 and prostate carcinoma: In prostate cancer (PC), PKIB is notably overexpressed in castration-resistant and aggressive subtypes, where it enhances cell growth and invasion by increasing the kinase activity of PKA-C and the phosphorylation of AKT [29].